Loading...

2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP)

BACKGROUND: ASPECT-NP, a phase 3, randomized, double-blind study, evaluated C/T (at double the approved dose for other indications) vs. meropenem (MEM) in adults with ventilated nosocomial pneumonia. We compared safety and efficacy outcomes from this trial among patients with and without renal impai...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Huntington, Jennifer A, Yu, Brian, Li, Linping, Jensen, Erin, Bruno, Christopher, Rhee, Elizabeth G
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810491/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1905
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!